Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK

INTRODUCTION: In patients with inflammatory bowel disease (IBD), iron deficiency anaemia (IDA) can impair quality of life and increase healthcare costs. Treatment options for IDA-associated IBD include oral iron and intravenous iron formulations (such as ferric carboxymaltose [FCM], ferric derisomal...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksan, Aysegül, Beales, Ian L P, Baxter, Garth, de Arellano, Antonio Ramirez, Gavata, Simona, Valentine, William J, Hunt, Barnaby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216635/
https://www.ncbi.nlm.nih.gov/pubmed/34168471
http://dx.doi.org/10.2147/CEOR.S306823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216635/
https://www.ncbi.nlm.nih.gov/pubmed/34168471
http://dx.doi.org/10.2147/CEOR.S306823

Ejemplares similares